Mindfulness program for African-Americans with type 2 diabetes
Official title: My ESSENCE - Mindfulness to Reduce Stress, Improve SIeep, and Reduce Cardiovascular Risk in African-Americans With Type 2 Diabetes
Run by University of Illinois Chicago · NCT05208164 · Data updated 2026-11-12
This study is testing a mindfulness meditation program to see if it can help African-American adults with type 2 diabetes sleep better and feel less stressed.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 75 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of Illinois Chicago Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | April 1, 2021 |
| Main results expected | May 31, 2025 |
| Study ends | July 31, 2025 |
| Registry record updated | March 5, 2025 |
| Trial ID | NCT05208164 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are African-American adults aged 21-75 with a diagnosis of type 2 diabetes living in the greater Chicagoland area.
✕Probably not a fit
Patients with untreated obstructive sleep apnea, severe insomnia, or those currently engaging in mindfulness practices may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This research focuses on a mindfulness meditation program aimed at improving sleep quality and reducing stress among African-American adults diagnosed with type 2 diabetes. The study will adapt an established mindfulness curriculum specifically for this population and will include text messaging support. It will involve an 8-week pilot randomized controlled trial with up to 100 participants, assessing the impact of the intervention on cardiometabolic risk factors and inflammatory biomarkers. Primary outcomes will be measured at baseline, 8 weeks, and 16 weeks to evaluate changes in sleep quality and perceived stress.
Why it matters
Potential benefit: If successful, this program could significantly reduce cardiovascular disease risk among African-Americans with type 2 diabetes.
How similar studies have gone: Other studies have shown promise in using mindfulness approaches to improve health outcomes, particularly in populations at risk for cardiovascular disease.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Self-identifies as African American or Black * Diagnosis of type 2 diabetes * Valid address in greater Chicagoland area * Mobile phone with unlimited text-messaging * Mobile device (smartphone, tablet, or computer) with the ability to connect to the internet if remote online delivery * Availability to participate in mindfulness class either in-person or online * Age 21-75 Exclusion Criteria * Untreated obstructive sleep apnea (OSA) * Severe insomnia, narcolepsy, or REM sleep related disorder * Major cognitive impairments or psychiatric disorder * Alcohol or drug abuse * Limited English proficiency * Inability to send/receive text messages * Currently engaging in mindfulness practice
Where it's running
-
University of Illinois at Chicago
Chicago, Illinois, United States Recruiting
Study contacts
- Principal investigator: Alana Biggers — University of Illinois Chicago
- Study coordinator: Alana Biggers, MD, MPH
- Email: abigger2@uic.edu
- Phone: 312-413-1793
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Acute Blood Flow Restriction Walking in Type 2 Diabetes
This study tests whether adding blood flow restriction to treadmill walking affects immune cells in adults with type 2 diabetes.
-
Continuous Glucose Monitoring in Type 2 Diabetes Not on Insulin
This study tests whether using a continuous glucose monitoring system helps people with type 2 diabetes who aren’t using insulin to improve blood sugar control and quality of life.
-
Differentiating heart disease in autoimmune vs. type 2 diabetes
This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.
-
Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses
This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.
-
Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar
This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.
-
Switching to Zenagamtide From Tirzepatide in Adults With Overweight or Obesity With or Without Type 2 Diabetes
This study tests whether adults who are overweight or have obesity (with or without type 2 diabetes) can switch from tirzepatide to a new treatment called zenagamtide to find a tolerable dose.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.